Home/Filings/4/0001001250-21-000067
4//SEC Filing

LAUDER RONALD S 4

Accession 0001001250-21-000067

CIK 0001001250other

Filed

May 4, 8:00 PM ET

Accepted

May 5, 4:53 PM ET

Size

11.1 KB

Accession

0001001250-21-000067

Insider Transaction Report

Form 4
Period: 2021-05-04
LAUDER RONALD S
Chairman, Clinique Labs, LLC10% Owner
Transactions
  • Sale

    Class A Common Stock

    2021-05-05$292.00/sh1,700,000$496,400,0000 total
  • Conversion

    Class A Common Stock

    2021-05-04+1,700,0001,700,000 total
  • Conversion

    Class B Common Stock

    2021-05-041,700,0005,468,846 total
    Class A Common Stock (1,700,000 underlying)
Holdings
  • Class B Common Stock

    (indirect: By Trust)
    Class A Common Stock (6,364 underlying)
    6,364
  • Class A Common Stock

    (indirect: By Trust)
    6,364
Footnotes (4)
  • [F1]Ronald S. Lauder ("RSL") converted shares of Class B Common Stock into an equal number of shares of Class A Common Stock.
  • [F2]There is no exercise or conversion price for the Class B Common Stock. Shares of Class B Common Stock (i) may be converted immediately on a one-for-one basis by the holder into shares of Class A Common Stock and (ii) are automatically converted into Class A Common Stock on a one-for-one basis upon transfer to a person or entity that is not a "Permitted Transferee" (as defined in Issuer's Restated Certificate of Incorporation) or soon after a record date for a meeting of stockholders where the outstanding Class B Common Stock constitutes less than 10% of the outstanding shares of Common Stock of the Issuer.
  • [F3]Not applicable.
  • [F4]RSL disclaims beneficial ownership of these shares to the extent he does not have a pecuniary interest in such securities.

Issuer

ESTEE LAUDER COMPANIES INC

CIK 0001001250

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0000942617

Filing Metadata

Form type
4
Filed
May 4, 8:00 PM ET
Accepted
May 5, 4:53 PM ET
Size
11.1 KB